Reply to McNally's comment on "Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience" by Steinhausen et al. (2021).
作者信息
Steinhausen Eva, Lefering Rolf, Glombitza Martin, Brinkmann Nikolaus, Vogel Carsten, Mester Bastian, Dudda Marcel
机构信息
Department of Orthopedic and Trauma Surgery, BG Klinikum Duisburg, University of Duisburg-Essen, 47249 Duisburg, Germany.
Department of Trauma, Hand and Reconstructive Surgery, University Hospital Essen, University of Duisburg Essen, Essen, Germany.
出版信息
J Bone Jt Infect. 2021 May 27;6(6):203-205. doi: 10.5194/jbji-6-203-2021. eCollection 2021.
Abstract
摘要
相似文献
1
Reply to McNally's comment on "Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience" by Steinhausen et al. (2021).对麦克纳利对施泰豪森等人（2021年）所著《生物活性玻璃S53P4与自体骨移植治疗慢性骨髓炎和感染性骨不连患者骨缺损的单中心经验》的评论的回复
J Bone Jt Infect. 2021 May 27;6(6):203-205. doi: 10.5194/jbji-6-203-2021. eCollection 2021.
2
Comment on "Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience" by Steinhausen et al. (2021).对施泰豪森等人（2021年）所著的《生物活性玻璃S53P4与自体骨移植治疗慢性骨髓炎和感染性骨不连患者骨缺损的单中心经验》的评论
J Bone Jt Infect. 2021 May 27;6(6):199-201. doi: 10.5194/jbji-6-199-2021. eCollection 2021.
3
Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience.生物活性玻璃S53P4与自体骨移植治疗慢性骨髓炎和感染性骨不连患者的骨缺损——单中心经验
J Bone Jt Infect. 2021 Jan 12;6(4):73-83. doi: 10.5194/jbji-6-73-2021. eCollection 2021.
4
The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients.生物活性玻璃S53P4作为骨移植替代物治疗慢性骨髓炎和感染性骨不连——50例患者的回顾性研究
Z Orthop Unfall. 2018 Apr;156(2):152-159. doi: 10.1055/s-0043-124377. Epub 2018 Apr 17.
5
Clinical outcomes and complications of S53P4 bioactive glass in chronic osteomyelitis and septic non-unions: a retrospective single-center study.S53P4 生物活性玻璃治疗慢性骨髓炎和感染性骨不连的临床疗效及并发症：一项回顾性单中心研究。
Eur J Clin Microbiol Infect Dis. 2024 Mar;43(3):489-499. doi: 10.1007/s10096-023-04737-z. Epub 2024 Jan 9.
6
Bioactive glass S53P4 to fill-up large cavitary bone defect after acute and chronic osteomyelitis treated with antibiotic-loaded cement beads: A prospective case series with a minimum 2-year follow-up.经抗生素载药珠治疗急性和慢性骨髓炎后，用生物活性玻璃 S53P4 填充大腔状骨缺损：一项最少 2 年随访的前瞻性病例系列研究。
Injury. 2021 Jul;52 Suppl 3:S23-S28. doi: 10.1016/j.injury.2021.05.030. Epub 2021 Jun 1.
7
Treatment of infected tibial non-unions using a BMAC and S53P4 BAG combination for reconstruction of segmental bone defects: A clinical case series.采用 BMAC 和 S53P4 BAG 联合治疗感染性胫骨骨不连，重建节段性骨缺损：临床病例系列研究。
Injury. 2021 Jun;52 Suppl 2:S67-S71. doi: 10.1016/j.injury.2020.09.029. Epub 2020 Sep 16.
8
Clinical Applications of S53P4 Bioactive Glass in Bone Healing and Osteomyelitic Treatment: A Literature Review.S53P4生物活性玻璃在骨愈合和骨髓炎治疗中的临床应用：文献综述
Biomed Res Int. 2015;2015:684826. doi: 10.1155/2015/684826. Epub 2015 Oct 4.
9
Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study.使用S53P4生物活性玻璃治疗慢性空洞性长骨骨髓炎的中期临床结果：一项多中心研究。
J Bone Jt Infect. 2021 Nov 12;6(9):413-421. doi: 10.5194/jbji-6-413-2021. eCollection 2021.
10
Treatment of Infection-Related Non-Unions with Bioactive Glass-A Promising Approach or Just Another Method of Dead Space Management?用生物活性玻璃治疗感染相关的骨不连——一种有前景的方法还是仅仅是另一种死腔处理方法？
Materials (Basel). 2022 Feb 24;15(5):1697. doi: 10.3390/ma15051697.
引用本文的文献
1
Nanoarchitectonics for Advancing Bone Graft Technology: Integration of Silver Nanoparticles Against Bacteria and Fungi.用于推进骨移植技术的纳米结构技术：银纳米颗粒对细菌和真菌的整合作用
Microorganisms. 2024 Dec 17;12(12):2616. doi: 10.3390/microorganisms12122616.
本文引用的文献
1
Comment on "Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience" by Steinhausen et al. (2021).对施泰豪森等人（2021年）所著的《生物活性玻璃S53P4与自体骨移植治疗慢性骨髓炎和感染性骨不连患者骨缺损的单中心经验》的评论
J Bone Jt Infect. 2021 May 27;6(6):199-201. doi: 10.5194/jbji-6-199-2021. eCollection 2021.
2
Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience.生物活性玻璃S53P4与自体骨移植治疗慢性骨髓炎和感染性骨不连患者的骨缺损——单中心经验
J Bone Jt Infect. 2021 Jan 12;6(4):73-83. doi: 10.5194/jbji-6-73-2021. eCollection 2021.
3
Treatment of fracture-related infection of the lower extremity with antibiotic-eluting ceramic bone substitutes: case series of 35 patients and literature review.抗生素洗脱陶瓷骨替代物治疗下肢骨折相关感染：35 例病例系列及文献复习。
Infection. 2020 Jun;48(3):333-344. doi: 10.1007/s15010-020-01418-3. Epub 2020 Apr 8.
4
Chronic Osteomyelitis of the tibia and ankle treated with Limb Salvage Reconstruction.采用保肢重建术治疗胫骨和踝关节慢性骨髓炎。
J Bone Jt Infect. 2019 Dec 10;4(6):306-313. doi: 10.7150/jbji.40337. eCollection 2019.
5
Augmented debridement for implant related chronic osteomyelitis with an absorbable, gentamycin loaded calcium sulfate/hydroxyapatite biocomposite.使用负载庆大霉素的可吸收硫酸钙/羟基磷灰石生物复合材料对植入物相关慢性骨髓炎进行强化清创术。
J Orthop. 2019 Aug 13;17:173-179. doi: 10.1016/j.jor.2019.08.017. eCollection 2020 Jan-Feb.
6
The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients.生物活性玻璃S53P4作为骨移植替代物治疗慢性骨髓炎和感染性骨不连——50例患者的回顾性研究
Z Orthop Unfall. 2018 Apr;156(2):152-159. doi: 10.1055/s-0043-124377. Epub 2018 Apr 17.
7
Antibacterial Bioactive Glass, S53P4, for Chronic Bone Infections - A Multinational Study.用于慢性骨感染的抗菌生物活性玻璃S53P4——一项多国研究
Adv Exp Med Biol. 2017;971:81-92. doi: 10.1007/5584_2016_156.
8
Clinical Application of Antimicrobial Bone Graft Substitute in Osteomyelitis Treatment: A Systematic Review of Different Bone Graft Substitutes Available in Clinical Treatment of Osteomyelitis.抗菌骨移植替代物在骨髓炎治疗中的临床应用：对骨髓炎临床治疗中可用的不同骨移植替代物的系统评价
Biomed Res Int. 2016;2016:6984656. doi: 10.1155/2016/6984656. Epub 2016 Jan 21.
9
Management of infected nonunion of the long bones by a multidisciplinary team.多学科团队对长骨感染性骨不连的治疗
Bone Joint J. 2015 Jun;97-B(6):814-7. doi: 10.1302/0301-620X.97B6.33276.
10
A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study.生物活性玻璃S53P4与载抗生素钙基骨替代物治疗慢性骨髓炎的对比研究：一项回顾性对比研究。
Bone Joint J. 2014 Jun;96-B(6):845-50. doi: 10.1302/0301-620X.96B6.33014.
Zotero 插件